NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Translate Bio Inc (NASDAQ: TBIO)

 
TBIO Technical Analysis
5
As on 9th Jun 2023 TBIO STOCK Price closed @ 1.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 22.86 & Strong Sell for SHORT-TERM with Stoploss of 17.42 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TBIOSTOCK Price

Open 1.37 Change Price %
High 1.56 1 Day 0.10 7.14
Low 1.37 1 Week -0.35 -18.92
Close 1.50 1 Month -0.93 -38.27
Volume 75930 1 Year -11.50 -88.46
52 Week High 37.85 | 52 Week Low 1.33
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
TBIO
Daily Charts
TBIO
Intraday Charts
Whats New @
Bazaartrend
TBIO
Free Analysis
 
TBIO Important Levels Intraday
RESISTANCE1.87
RESISTANCE1.75
RESISTANCE1.68
RESISTANCE1.60
SUPPORT1.40
SUPPORT1.32
SUPPORT1.25
SUPPORT1.13
 
TBIO Forecast May 2024
4th UP Forecast24.1
3rd UP Forecast16.85
2nd UP Forecast12.37
1st UP Forecast7.89
1st DOWN Forecast-4.89
2nd DOWN Forecast-9.37
3rd DOWN Forecast-13.85
4th DOWN Forecast-21.1
 
TBIO Weekly Forecast
4th UP Forecast5.32
3rd UP Forecast4.09
2nd UP Forecast3.34
1st UP Forecast2.58
1st DOWN Forecast0.42
2nd DOWN Forecast-0.34
3rd DOWN Forecast-1.09
4th DOWN Forecast-2.32
 
TBIO Forecast2024
4th UP Forecast72.2
3rd UP Forecast49.53
2nd UP Forecast35.51
1st UP Forecast21.5
1st DOWN Forecast-18.5
2nd DOWN Forecast-32.51
3rd DOWN Forecast-46.53
4th DOWN Forecast-69.2
 
 
TBIO Other Details
Segment EQ
Market Capital 2823919360.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
TBIO Address
TBIO
 
TBIO Latest News
 
Your Comments and Response on Translate Bio Inc
 
TBIO Business Profile
Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis. It is also developing MRT5500 for the treatment of SARS-CoV-2. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. has a collaboration and license agreement with Sanofi Pasteur Inc. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. As of September 13, 2021, Translate Bio, Inc. operates as a subsidiary of Sanofi. Address: 29 Hartwell Avenue, Lexington, MA, United States, 02421
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service